Virulence and transmissibility of H1N2 influenza virus in ferrets imply the continuing threat of triple-reassortant swine viruses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 39, 2012, Pages 15900-15905

  Pascua, Philippe Noriel Q ^a   Song, Min Suk ^a   Lee, Jun Han ^a   Baek, Yun Hee ^a   Kwon, Hyeok Il ^a   Park, Su Jin ^a   Choi, Eun Hye ^a   Lim, Gyo Jin ^a   Lee, Ok Jun ^a   Kim, Si Wook ^a   Kim, Chul Joong ^b   Sung, Moon Hee ^c   Kim, Myung Hee ^d   Yoon, Sun Woo ^e   Govorkova, Elena A ^e   Webby, Richard J ^e   Webster, Robert G ^e   Choi, Young Ki ^a  

^a Chungbuk National University College of Medicine   (South Korea)

^b Chungnam National University   (South Korea)

^c Bioleaders Corporation   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^e ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Evolution; Interspecies transmission; Severe disease; Viral segments

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

AMINO ACID SUBSTITUTION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N2; INFLUENZA VIRUS A H3N2; MOUSE; NONHUMAN; PRIORITY JOURNAL; SWINE; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; CELL LINE; DOGS; FERRETS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS, H1N2 SUBTYPE; MICE; MUTATION; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; SWINE DISEASES; VIRULENCE FACTORS;

ANIMALIA; INFLUENZA A VIRUS; MAMMALIA; MUS; MUSTELA; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 84866867147     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1205576109     Document Type: Article

References (35)

1. Ito T, et al. (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72:7367-7373. (Pubitemid 28377868)
2. Scholtissek C (1990) Pigs as the "mixing vessel'" for the creation of new pandemic influenza A viruses. Med Principles Pract 2:65-71.
3. Garten RJ, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325:197- 201.
4. Trifonov V, Khiabanian H, Greenbaum B, Rabadan R (2009) The origin of the recent swine influenza A(H1N1) virus infecting humans. Euro Surveill 14:pii 19193.
5. Childs RA, et al. (2009) Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nat Biotechnol 27:797-799.
6. Hale BG, et al. (2010) Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus. J Gen Virol 91:1737-1742.
7. Song MS, et al. (2011) Virulence and genetic compatibility of polymerase reassortant viruses derived from the pandemic (H1N1) 2009 influenza virus and circulating influenza A viruses. J Virol 85:6275-6286.
8. Zhou NN, et al. (1999) Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol 73:8851-8856. (Pubitemid 29441754)
9. Gray GC, et al. (2007) Swine workers and swine influenza virus infections. Emerg Infect Dis 13:1871-1878. (Pubitemid 350248489)
10. Shinde V, et al. (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 360:2616-2625.
11. Choi YK, Pascua PN, Song MS (2012) Swine influenza viruses: An Asian perspective. Curr Top Microbiol Immunol, 10.1007/82-2011-195.
12. Pascua PN, et al. (2008) Seroprevalence and genetic evolutions of swine influenza viruses under vaccination pressure in Korean swine herds. Virus Res 138:43-49.
13. Govorkova EA, et al. (2005) Lethality to ferrets of H5N1 in fluenza viruses isolated from humans and poultry in 2004. J Virol 79:2191-2198. (Pubitemid 40204576)
14. Hampson AW (2006) Ferrets and the challenges of H5N1 vaccine formulation. J Infect Dis 194:143-145.
15. Mehle A, Doudna JA (2009) Adaptive strategies of the influenza virus polymerase for replication in humans. Proc Natl Acad Sci USA 106:21312-21316.
16. Medina RA, García-Sastre A (2011) Influenza A viruses: New research developments. Nat Rev Microbiol 9:590-603.
17. Colman PM (1994) Influenza virus neuraminidase: Structure, antibodies, and inhibitors. Protein Sci 3:1687-1696.
18. Zhu H, et al. (2011) Novel reassortment of Eurasian avian-like and pandemic/2009 influenza viruses in swine: Infectious potential for humans. J Virol 85:10432-10439.
19. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97:6108-6113. (Pubitemid 30367531)
20. Belser JA, et al. (2011) Pathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic. J Virol 85:1563-1572.
21. Yen HL, et al. (2011) Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc Natl Acad Sci USA 108:14264-14269.
22. Tumpey TM, et al. (2007) A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315:655-659. (Pubitemid 46214711)
23. Maines TR, et al. (2009) Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325:484-487.
24. Ning ZY, et al. (2009) Detection of expression of infl uenza virus receptors in tissues of BALB/c mice by histochemistry. Vet Res Commun 33:895-903.
25. Shinya K, et al. (2006) Avian flu: Influenza virus receptors in the human airway. Nature 440:435-436.
26. Liu Y, et al. (2010) Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol 84:12069-12074.
27. Chan PK, et al. (2011) Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus. J Clin Virol 50:320-324.
28. Kilander A, Rykkvin R, Dudman SG, Hungnes O (2010) Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill 15:pii 19498.
29. Mak GC, et al. (2010) Association of D222G substitution in haemagglutinin of 2009 pandemic influenza A (H1N1) with severe disease. Euro Surveill 15:pii 19534.
30. Tse H, et al. (2011) Clinical and virological factors associated with viremia in pandemic influenza A/H1N1/2009 virus infection. PLoS ONE 6:e22534.
31. Watanabe T, et al. (2011) Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J Virol 85:13195-13203.
32. Chutinimitkul S, et al. (2010) Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J Virol 84:11802-11813.
33. Puzelli S, et al.; Surveillance Group for Pandemic A H1N1 2009 Influenza Virus in Italy (2010) Transmission of hemagglutinin D222G mutant strain of pandemic (H1N1) 2009 virus. Emerg Infect Dis 16:863-865.
34. Couceiro JN, Baum LG (1994) Characterization of the hemagglutinin receptor specificity and neuraminidase substrate specificity of clinical isolates of human influenza A viruses. Mem Inst Oswaldo Cruz 89:587-591.
35. Wagner R, Matrosovich M, Klenk HD (2002) Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 12:159-166. (Pubitemid 34516947)